Enasidenib Mesylate + Anti Fungal Agents That Are Cyp3a4 Substrates Interaction
Majorinteraction on record
Description
Do not administer enasidenib with anti-fungal agents that are CYP3A substrates due to expected loss of antifungal efficacy.
Mechanism
CYP3A induction leading to decreased antifungal exposure
Source: NLP:enasidenib mesylate